Share chart Akari Therapeutics, Plc
Extended chart
Simple chart
About Akari Therapeutics, Plc
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. more details| IPO date | 2015-09-21 |
|---|---|
| ISIN | US00972G1085 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.akaritx.com |
| Цена ао | 1.89 |
| Change price per day: | -1.2% (0.98) |
|---|---|
| Change price per week: | -0.1856% (0.97) |
| Change price per month: | -13.55% (1.12) |
| Change price per 3 month: | -67.07% (2.94) |
| Change price per half year: | -68.77% (3.1) |
| Change price per year: | -68.97% (3.12) |
| Change price per 3 year: | -37.54% (1.55) |
| Change price per 5 year: | -48.22% (1.87) |
| Change price per 10 year: | 0% (0.9682) |
| Change price per year to date: | -60.16% (2.43) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Sabby Management, LLC | 164026 | 2.07 |
| Omnia Family Wealth, LLC | 87628 | 1.11 |
| Cerity Partners LLC | 23643 | 0.3 |
| Renaissance Technologies, LLC | 10269 | 0.13 |
| Bank of America Corporation | 150 | 0 |
| Truvestments Capital, LLC | 50 | 0 |
| Morgan Stanley | 8 | 0 |
| Tower Research Capital LLC (TRC) | 7 | 0 |
| Cornerstone Planning Group LLC | 5 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Wendy F. DiCicco CPA | Interim Chief Financial Officer | 540.34k | 1967 (58 years) |
| Dr. Miles Nunn | Chief Scientific Officer | N/A | 1969 (56 years) |
| Dr. Samir Rashmikant Patel M.D. | Interim President, CEO & Director | 3.7k | 1969 (56 years) |
Address: United Kingdom, London WG RT, 75/76 Wimpole Street - open in Google maps, open in Yandex maps
Website: https://www.akaritx.com
Website: https://www.akaritx.com
